Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score

Published:2013-12 Issue:12 Volume:15 Page:1002-1009
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Dumitra Sinziana,Jamal Mohammad H.,Aboukhalil Jad,Doi Suhail A.,Chaudhury Prosanto,Hassanain Mazen,Metrakos Peter P.,Barkun Jeffrey S.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Epidemiology and risk factors for pancreatic cancer;Lowenfels;Best Pract Res Clin Gastroenterol,2006

2. Adjuvant therapy for pancreatic cancer: one small step forward;Benson;JAMA,2007

3. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction;Smith;Lancet,1994

4. Unresectable pancreatic adenocarcinoma: do we know who survives?;Jamal;HPB,2010

5. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation;Krishnan;Cancer,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas;Updates in Surgery;2023-08-03

2. [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2023-06-17

3. The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer;Annals of Surgical Oncology;2022-09-19

4. New Cancer-Related Symptoms Predict Recurrence in CA19-9 Non-Expressers After Resection of Pancreatic Ductal Adenocarcinoma;The American Surgeon;2022-08-03

5. The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study;Journal of Oncology;2021-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3